Clinical Trial: Proton Dose Escalation for Patients With Atypical or Anaplastic Meningiomas

Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional




Official Title: Proton Dose Escalation for Patients With Atypical or Anaplastic Meningiomas

Brief Summary: The trial evaluates the effect of a moderately increased radiation dose in patients with atypical (grade II) and anaplastic (grade III) meningioma after incomplete or no surgery. Endpoint is recurrence-free survival after 5 years.